A new study suggests that semaglutide, a popular diabetes medication, could be linked to a lower risk of opioid overdose in patients with type 2 diabetes and opioid use disorder. This finding could open doors for a new use of this blockbuster drug, but more research is needed to confirm its efficacy and investigate the underlying mechanisms.